National Comprehensive Cancer Network

Educational Events & Programs

NCCN Academy for Excellence & Leadership in Oncology™
School of Pharmaceutical & Biotech Business

Tuesday, July 14, 2015
8:20 AM – 2:15 PM
(Breakfast and registration begin at 7:30 AM)

The Rittenhouse Hotel
Philadelphia, PA

Save $100 and register by Friday, June 12, 2015!

Overview

Pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider and payer perspective. Participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology and will gather valuable insights material to developing effective strategies for navigating the various constituencies in cancer care. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.

Professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

Please check back often for additional updates regarding this program. If you have any questions, please contact Jennifer Tredwell, Senior Director, Marketing.


Moderator:

Clifford Goodman, PhD
Senior Vice President
The Lewin Group


Curriculum*:

7:30 – 8:15 AM
Breakfast and Registration

8:20 – 8:25 AM
Welcome
C. Lyn Fitzgerald, MJ
Vice President, U.S & Global Development
National Comprehensive Cancer Network

8:30 – 10:00 AM
Module I: New Trends in Utilization Management Strategies for Systematic Therapies and Diagnostics
Invited Panelists:
Dane Dickson
CEO, Molecular Evidence Development Consortium
Med-C

Matthew Farber
Senior Director, Oncology Disease State
Walgreens Co.

John Fox, MD, MHA
Associate Vice President of Medical Affairs
Priority Health

Elaine Jeter
Medical Director
Palmetto GBA

Steve Miller, MD
Senior Vice President and Chief Medical Officer
Express Scripts

10:00 – 10:10 AM
Break

10:15 – 11:40 AM
Module II: Improving Patient Engagement; Using Technology to Support the Navigation and Delivery of Quality Cancer Care
Invited Panelists:
Loreen Brown, MSW
Senior Vice President of Product Management and Not-for-Profit Operations
Lash Group, AmerisourceBergen

Jeff Pollard, MD
Director of Medical Affairs
23 and Me

Gabriel Eichler, PhD
General Manager, Client Services & Strategic Initiatives
Patients Like Me

Matthew Farber
Senior Director, Oncology Disease State
Walgreens Co.

Mark Redlus
Senior Vice President of Labs and Innovation
Polaris Health Directions

Ronald S. Walters, MD, MBA, MHA, MS
Associate VP of Medical Operations & Informatics
Professor, Brest Medical Oncology
The University of Texas MD Anderson Cancer Center

11:40 AM – 12:25 PM
Lunch

12:30 – 2:00 PM
Module III: Meet the NCCN Guidelines Experts; Chronic Myelogenous Leukemia, Melanoma, Multiple Myeloma, Myeloid Growth Factors, Non-Hodgkin’s Lymphomas
Panelists:
Kenneth C. Anderson, MD (Multiple Myeloma)
Kraft Family Professor of Medicine, Harvard Medical School
Director, LeBow Institute for Myeloma Therapeutics
Director, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute

Robert W. Carlson, MD
Chief Executive Officer,
National Comprehensive Cancer Network

Jeffrey Crawford, MD (Myeloid Growth Factors)
George Barth Geller Professor for Research in Cancer
CoDirector, Solid Tumor Therapeutics Program,
Duke Cancer Institute

Michael Deininger, MD, PhD (CML) – pending
Chief, Division of Hematology and Hematologic Malignancies
M.M. Wintrobe Professor of Medicine
Huntsman Cancer Institute at the University of Utah

Leo I. Gordon, MD (Non-Hodgkin’s Lymphomas)
Abby & John Friend Professor of Cancer Research, Professor in Medicine Director, Lymphoma Program
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Anthony J. Olszanski, RPh, MD (Melanoma)
Director, Phase 1 Development Therapeutics Program
Director, Medical Oncology Melanoma Program
Fox Chase Cancer Center


2:05 – 2:15 PM
Closing Remarks         
Gary J. Weyhmuller, MBA, SPHR
Executive Vice President, Chief Operating Officer
National Comprehensive Cancer Network

*Subject to change.


Program Location:

The Rittenhouse Hotel
210 West Rittenhouse Square
Philadelphia, Pennsylvania 19103

Tuition Information:

   
  By 6.12.2015 After 6.12.2015
Academy Alumni$795$895
Industry Registrants$1,195$1,295
NCCN Corporate Council Members$1,095$1,195
Ten or more people from the same company$1,050$1,050

 

Accommodations:

We currently have a room block for the night of Monday, July 13, 2015. Attendees may book a room by calling Rittenhouse Hotel Reservations at 1.800.635.1042. Please be sure to state that you are attending NCCN Academy.

A discounted rate of $249 has been negotiated for NCCN attendees. Please book your room by Friday, June 12, 2015 to receive the discounted rate. Early booking is strongly recommended.


License NCCN Academy Video Modules!

Permission licenses are available to purchase exclusive video footage of recent NCCN Academy for Excellence & Leadership in Oncology&trade School of Pharmaceutical & Biotech Business programs for viewing by internal company representatives for one year.

Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.


Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.